Bone | Biomaterials | Diagnosis
Here at NOVUS, we put our innovative, patented technologies into practice, bringing novel solutions to the market.
#Pioneer_in_Biomaterials
NOVUS Life Sciences is a biomedical company with a vision to advance healthcare through material sciences. Headquartered in Hong Kong, we have become a global leader in the formulation of biomaterials through 3d printing of implants and related medical devices.
Since our incubation, we have expanded our operations to over 50 countries, serving clients in top hospitals, universities, and industry partners. Our mission is to deliver biomaterials that are not only engineered for precision, but designed under strict adherence to ISO protocol for applications in the medical and veterinary fields.
#Our Technology
Through our state of the art nanomaterial technology, nano-hydroxyapatite crystals sized 20 nm are chemically bonded on acrylic based co-polymers which forms the building block of our flagship product, Bonlecule. Bonlecule is a groundbreaking bioactive 3D printing biomaterial that possesses superior biological and mechanical properties. Instead of improving bioactivity through filler materials or coating, which contributes to heterogenicity and blockage during 3D printing, the incorporation of nano-hydroxyapatite coated copolymer is engineered to demonstrate excellent hydroxyapatite dispersion in the filament matrix as proven under transmission electron microscopy that perfect the printing experience in any commercial 3D printers for any level of 3D printer users.
​
The incorporation of nano-particles in the polymer matrix during filament extrusion is engineered to produce excellent dispersion as proven under transmission electron microscopy and to perfect the printing experience in any commercial 3D printer. All manufacturing takes place in our ISO 14644-1 Class 10,000 cleanroom and is under strict quality control governed by ISO 13485.
​​
Our flagship product, Bonlecule™ is a groundbreaking functional biomaterial which possesses superior biological and comparable mechanical properties. Instead of conventional biomaterials improve bioactivity through filler materials or coatings which contributes to the brittleness and the filament may break at the printer nozzle. The solution to this limitation is to utilize bioactive nano-particles with engineered dispersion process during production.
Quality-Assured, Compliant Medical Grade Filaments
To meet the demanding requirements of the medical device industry, Novus provides OSSFILA® medical-grade 3D printing filaments manufactured to the highest quality standards. Designed specifically for additive manufacturing of medical components and implants, these filaments offer reliable performance and proven safety.
​
Each OSSFILA® material is evaluated for biocompatibility in accordance with ISO 10993 or USP Class VI standards. Production takes place in an ISO 14644-1 Class 10,000 cleanroom, under strict quality management systems certified to ISO 13485.
​
This comprehensive approach ensures a trusted material solution that ensures both compliance and confidence in medical device manufacturing.
Groundbreaking Nano-Particles
During past seven years, we achieved a breakthrough with our nano-material synthesis and nano-coating methods, and have since successfully applied such technologies to our bone filler formulation and implants. Our nano-coating share the same basic structure with the body’s natural bone mineral, yielding a higher biocompatibility. The nano-particles that we created can assist bone growth and plays a crucial role in our bone cement formula and implant materials.
Clinically Proven
Our hydroxyapatite-PMMA based Veterinary Adhesives has been clinically proven to mimic the chemical composition of natural bone to enhance healing and provide immediate stability. More bone formation was shown compared to conventional PMMA. Our Veterinary Adhesive series present comparable mechanical properties to natural bones. Its excellent adherence makes them suitable for wide range of applications.
